跳至主要内容
临床试验/ACTRN12611000741987
ACTRN12611000741987招募中未知

Paracetamol Duct Action(PDA) Trial: The effect of paracetamol vs placebo on ductal closure in premature infants with a late patent ductus arterious

A/Professor Martin Kluckow0 个研究点目标入组 60 人开始时间: 2011年7月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
4 Weeks 至 20 Weeks(—)
性别
All

入选标准

  • 1.Babies with a persistent PDA born <33 weeks gestational age who are >4 weeks of postnatal age and tolerating at least 50% (i.e. 80ml/kg/day) of enteral feeds
  • 2.Echocardiographic findings of a PDA with a Colour Doppler duct size more than 1.5mm with pulsatile pattern with or without oxygen and/or CPAP support.
  • 3.Informed written parental consent

排除标准

  • 1.PDA with evidence of congestive cardiac failure, signs include tachycardia; venous congestion; high catecholamine levels; and, ultimately, insufficient cardiac output with poor perfusion and end-organ compromise.
  • 2.Abnormal liver function tests :
  • a.Elevated alanine transaminase (twice normal level for corrected gestation)
  • b.Elevated aspartate transaminase (twice normal level for corrected gestation)
  • c.Elevated conjugated bilirubin (>80mmol/L)

研究者

发起方
A/Professor Martin Kluckow

相似试验